Evidence map›Paper›PMID 33075539›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2021

SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic.

Usha Venugopal, Nargis Jilani, Sami Rabah, Masood A Shariff, Muzamil Jawed, Astrid Mendez Batres, Muhamed Abubacker, Sharika Menon, Anjana Pillai, Nehad Shabarek and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 7 pooled it
2.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 7 syntheses or guidelines pooled it, 128 citations in OpenAlex.

  1. Pooled it
  2. Effectiveness of face masks for reducing transmission of SARS-CoV-2: a rapid systematic review.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2023
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Pooled it
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Effect of vaccine dose onJournal of education and health promotion · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Transmission and Risk Factors of COVID-19 among Health Care Workers.Seminars in respiratory and critical care medicine · 2023
    Review
  20. Seroprevalence of SARS-CoV-2 in hospital workers in the southern region of Minas Gerais state in Brazil: An analysis of the pre-vaccine period.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Usha VenugopalDepartment of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Nargis JilaniDepartment of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Sami RabahDepartment of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Masood A ShariffDepartment of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Muzamil JawedDepartment of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Astrid Mendez BatresDepartment of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Muhamed AbubackerDepartment of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Sharika MenonDepartment of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Anjana PillaiDepartment of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Nehad ShabarekDepartment of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Moiz KasubhaiDepartment of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Vihren DimitrovDepartment of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Vidya MenonDepartment of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA. Electronic address: menonv@nychhc.org.
Lincoln Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNew York City (NYC) has endured the greatest burden of COVID-19 infections in the US. Health inequities in South Bronx predisposed this community to a large number of infectious cases, hospitalizations, and mortality. Health care workers (HCWs) are at a high risk of exposure to the infection. This study aims to assess seroprevalence and the associated characteristics of consenting HCWs from an NYC public hospital.

methodsThis cross-sectional study includes serum samples for qualitative SARS-CoV-2 antibody testing with nasopharyngeal swabs for SARS-CoV-2; PCR and completion of an online survey capturing demographics, COVID-19 symptoms during the preceding months on duty, details of healthcare and community exposure, and travel history were collected from consenting participants in May 2020. Participants' risk of exposure to COVID-19 infection in the hospital and in the community was defined based on CDC guidelines. Travel history to high-risk areas was also considered an additional risk. The Odds Ratio with bivariable and multivariable logistic regression was used to assess characteristics associated with seroprevalence.

resultsA total of 500 HCW were tested, 137 (27%) tested positive for the SARS-CoV-2 antibody. Symptomatic participants had a 75% rate of seroconversion compared to those without symptoms. Subjects with anosmia and ageusia had increased odds of seroconversion in comparison to those without these symptoms. Community exposure was 34% among those who had positive antibodies.

conclusionSeroprevalence among HCWs was high compared to the community at the epicenter of the pandemic. Further studies to evaluate sustained adaptive immunity in this high-risk group will guide our response to a future surge.

Indexed as

COVID-19 Serological TestingHealth PersonnelAdultCOVID-19COVID-19 Nucleic Acid TestingCross-Sectional StudiesFemaleHospitals, UrbanHumansMaleMiddle AgedNew York CityPandemicsSARS-CoV-2Seroepidemiologic StudiesAntibodyCOVID-19ExposureHealth care workersSARS-CoV-2 PCRSeroprevalence

Identifiers

PMID33075539
PMCPMC7566823
OpenAlexW3092655831

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.